共 50 条
- [41] Blastic plasmacytoid dendritic cell neoplasm (BPDCN) - clinical features, diagnosis, and treatment in the experience from a single institutionONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (06): : 230 - 238Targonski, LukaszKwapisz, DorotaRymkiewicz, GrzegorzWalewski, Jan
- [42] Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasmLEUKEMIA, 2014, 28 (04) : 823 - 829Menezes, J.Acquadro, F.Wiseman, M.Gomez-Lopez, G.Salgado, R. N.Talavera-Casanas, J. G.Buno, I.Cervera, J. V.Montes-Moreno, S.Hernandez-Rivas, J. M.Ayala, R.Calasanz, M. J.Larrayoz, M. J.Brichs, L. F.Gonzalez-Vicent, M.Pisano, D. G.Piris, M. A.Alvarez, S.Cigudosa, J.
- [43] Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCNCurrent Hematologic Malignancy Reports, 2017, 12 : 592 - 597Naveen PemmarajuAudun UtengenVikas GuptaMichael A. ThompsonAndrew A. Lane
- [44] Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell NeoplasmCLINICAL CANCER RESEARCH, 2011, 17 (19) : 6163 - 6173Agliano, AliceMartin-Padura, InesMarighetti, PaolaGregato, GiulianaCalleri, AngelicaPrior, CeliaRedrado, MiriamCalvo, AlfonsoBertolini, Francesco
- [46] CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsLEUKEMIA RESEARCH, 2022, 121Pemmaraju, NaveenWilson, Nathaniel R.Senapati, JayastuEconomides, Minas P.Guzman, Monica L.Neelapu, Sattva S.Kazemimood, RossanaDavis, Richard EricJain, NitinKhoury, Joseph D.Sugita, MayumiCai, TianyuSmith, JulianneFrattini, Mark G.Garton, AndrewRoboz, GailKonopleva, Marina
- [47] Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agentsANNALS OF HEMATOLOGY, 2018, 97 (04) : 563 - 572Wang, ShunanWang, XingtongLiu, MingsuoBai, Ou
- [48] First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three casesJOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11Sun, WeiliLiu, HuayingKim, YoungKarras, NicolePawlowska, AnnaToomey, DebbieKyono, WadeGaynon, PaulRosenthal, JosephStein, Anthony
- [49] Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review.LEUKEMIA RESEARCH REPORTS, 2022, 17Abla, DimaAbboud, Miguel R.Noun, DollyTarek, NidalePemmaraju, Naveen
- [50] Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetHAEMATOLOGICA, 2019, 104 (04) : 729 - 737Sapienza, Maria RosariaAbate, FrancescoMelle, FedericaOrecchioni, StefaniaFuligni, FabioEtebari, MaryamTabanelli, ValentinaLaginestra, Maria AntonellaPileri, AlessandroMotta, GiovannaRossi, MauraAgostinelli, ClaudioSabattini, ElenaPimpinelli, NicolaTruni, MauroFalini, BrunangeloCerroni, LorenzoTalarico, GiovannaPiccioni, RossanaAmente, StefanoIndio, ValentinaTarantino, GiuseppeBrundu, FrancescoPaulli, MarcoBerti, EmilioFacchetti, FabioDellino, Gaetano IvanBertolini, FrancescoTripodo, ClaudioRabadan, RaulPileri, Stefano A.